Results 391 to 400 of about 256,813 (405)
Some of the next articles are maybe not open access.

Allogeneic Transplantation of Hematopoietic Stem Cells

2012
Molecular and cytometric studies of human hematopoietic stem cells and its microenvironment have greatly contributed to a better understanding of their biology, including regulation of their function and mutual interaction. This has resulted in the improvements of the procedure of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for ...
openaire   +2 more sources

Development of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

2002
The field of BMT has entered a new phase based on insights into basic molecular and cellular biology. The mechanism of cure mediated by allogeneic HSCT is now believed to be at least partially mediated by cellular attack against tumor-associated antigens.
Januario E. Castro, Edward D. Ball
openaire   +3 more sources

Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes

Clinical Lymphoma Myeloma and Leukemia, 2013
Allogeneic stem cell transplantation (SCT) is the only treatment with curative potential for myelodysplastic syndrome (MDS). The availability of SCT has been expanded with the introduction of reduced intensity conditioning for older patients and the use of alternative donors.
Borje S. Andersson   +3 more
openaire   +3 more sources

Outcome Predictors of Allogeneic Hematopoietic Stem Cell Transplant

The American Journal of the Medical Sciences, 2013
Acute kidney injury (AKI) is a significant complication after hematopoietic stem cell transplantation (HSCT) and frequently limits treatment success. Patients suffering complications with AKI often have high mortality. This investigation analyzed the outcomes of patients receiving allogeneic HSCT and identified the association between prognosis and ...
Po-Nan Wang   +21 more
openaire   +3 more sources

Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis

2011
Hematopoietic stem cell transplantation offers a curative therapy for patients with myelofibrosis. Due to toxicity, allografting following myeloablative regimens is mainly applicable to young patients. With the introduction of dose-reduced conditioning using busulfan or melphalan with fludarabine, transplantation became tolerable also in older patients.
openaire   +2 more sources

Transfusion policy in allogeneic hematopoietic stem cell transplantation

Transfusion and Apheresis Science, 2018
The incompatibility of ABO blood group between the recipient and the donor is not a barrier to perform allogeneic hematopoietic stem cell transplantation (Allo-HSCT). However, ABO incompatibility may lead to many complications during and after stem cell transplantation at the early or late period.
openaire   +2 more sources

Allogeneic hematopoietic stem cell transplantation

, 2017
R. Seger   +4 more
semanticscholar   +1 more source

[Nursing care and allogeneic hematopoietic stem cell transplantation.]

Soins, 2021
J. Guichard, L. Gaillard, Ludovic Leroux
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy